Biosimilars Blog
RF 360

In the News

Insightful. Precise. Skilled.

Rothwell Figg and Eight Attorneys Named Among the World's Leading Patent Professionals in 2019 Edition of IAM Patent 1000

June 6, 2019

Rothwell Figg and eight firm partners are recognized in the 2019 edition of IAM Patent 1000 – The World’s Leading Patent Professionals, a unique guide that shines a spotlight on the firms and individuals that are deemed outstanding in the pivotal area of patents. The number of ranked attorney is up from six in 2018.

The firm is ranked in the DC metro area in the fields of patent litigation and prosecution. 

The Rothwell Figg attorneys, recognized via input from peers and clients, are:

  • E. Anthony Figg – identified as a Luminary in the DC metro area
  • Steven Lieberman – ranked in litigation in the DC metro area
  • Joseph A. Hynds – ranked in litigation in the DC metro area; ranked in post-grant proceedings nationally
  • Martin M. Zoltick – ranked in prosecution and litigation in the DC metro area; ranked in post-grant proceedings nationally
  • R. Danny Huntington – ranked in prosecution in the DC metro area; ranked in post-grant proceedings nationally
  • Sharon L. Davis – ranked in litigation in the DC metro area
  • Steven P. Weihrouch - ranked in litigation in the DC metro area
  • Robert P. Parker - ranked in litigation in the DC metro area

The eighth edition of the guide includes the rich description below of the firm and the ranked attorneys:

“An excellent litigation firm that practices with the utmost integrity” is the verdict on DC boutique Rothwell Figg. “Its litigators are deeply and broadly knowledgeable, they think strategically and are excellent at communicating with their clients on the progress of their cases. They are also very mindful of controlling costs.” Trial lawyers do not come better than Steven Lieberman, an “extremely aggressive advocate but one who never crosses the line”. He manages a colossal workload without ever dropping the ball on his cases; lately, he has secured several favourable decisions under Section 101 for Fandango and got a case filed by Moving Media Nordic against his client Big Ten Networks dismissed for no payment or licensing agreement. He makes a great team with Sharon Davis, who is cherished by high-tech and pharmaceutical patrons alike for her crystal-clear, to-the-point advocacy. Rothwell Figg has two new faces in the IAM Patent 1000 this year in Steven Weihrouch and Robert Parker, both accomplished litigators. Weihrouch has an ardent following of Japanese companies – he worked in Japan for two years as a foreign attorney – and has lately been representing leading LED manufacturer Nichia in a slew of litigations against competitors including Feit Electric and Vizio. Parker “understands his clients’ business needs and looks for solutions to complex international disputes that align with them”. “He is incredibly knowledgeable and experienced, and represents with zeal.” He was in on the Nichia action, as was Martin Zoltick, who has much to offer in the form of litigation, post-grant and prosecution expertise and thought leadership on emerging technology areas such as blockchain. Also worthy of special mention are the firm’s outstanding life sciences litigation and post-grant proceedings practices. With pioneer Anthony Figg on deck, the set is steeped in Hatch-Waxman Act litigation like few others, though it has also been making a strong push with respect to biologic drug and biosimilar matters; Figg and Joseph Hynds, a star of both the aforementioned practices, have recently filed numerous inter partes review petitions for biosimilar drug developer Coherus BioSciences. Danny Huntington is another repository of trust for biotechnology and pharmaceutical companies and much respected in the post-grant world thanks to his interference expertise, which he continues to build on; his work highlights include securing a finding of no interference in fact for EDITAS Medicine, a licensee of the Broad Institute, in a matter involving CRISPR gene editing.

The 2019 edition of the IAM Patent 1000 guide was compiled following an extensive research process. Over five months, IAM conducted almost 1,800 interviews with numerous attorneys at law, patent attorneys, and in-house counsel to gather market intelligence on the leading players in the field. Individuals qualify for a listing in the IAM Patent 1000 when they receive sufficient positive feedback from peers and clients with knowledge of their practice and the market within which they operate. Only those individuals identified by market sources for their exceptional skill sets and profound insights into patent matters feature in the IAM Patent 1000. The 2019 guide also identifies the leading firms in the market. Firms qualify for a listing on the basis of their depth of expertise, market presence, and the level of work on which they are typically engaged.

To see the full 2019 rankings, and to learn more about IAM Patent 1000, please visit